Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have stable chest pain (angina) or have had a recent heart attack with at least one other stable, narrowed heart artery that was not the direct cause of the heart attack
- People who have one or more significantly narrowed coronary arteries (the blood vessels supplying the heart) that the treating doctor considers suitable for placing a stent directly, without needing to pre-open the artery first
- People who are at least 18 years old
- People who have given written agreement to take part in the study
Who may not be able to join:
- People whose artery blockage is too severe (nearly or completely blocked) or too heavily calcified for a stent to be placed directly
- People whose artery narrowing caused their most recent heart attack — although those same people may still be considered for the trial if other stable, narrowed arteries remain that could be treated separately
- People whose artery narrowing is in a location that makes it difficult to use the specialised imaging equipment required by this trial — for example, at the very start of major arteries, in bypass grafts, or in arteries with very twisting paths
- People who need treatment for a previously placed stent that has re-narrowed
- People whose artery narrowing is at a branching point where a two-stent approach or a specific type of balloon widening is planned
- People who need treatment of a coronary bypass graft
- People whose kidneys are not working well enough (confirmed by a specific kidney function measurement) (confirm with trial site)
- People with a known allergy or sensitivity to cobalt chromium (a metal used in stents)
- People with a serious illness that means they are not expected to live for more than one year
- People who are unable to understand the study instructions or follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rohit Oemrawsingh, MD, PhD, Albert Schweitzer Hospital
Phone: 0786541492
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Suboptimal stent results which is defined as a composite of major stent underexpansion and major edge dissection measured by OCT at lesion level directly after completion of the stent implantation according to the protocol
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.